
Butyrate: The Microbiome's Anti-Aging "Kill Switch" For Senescent Cells
Recent research highlights butyrate—a short‑chain fatty acid produced by gut microbes—as a potent anti‑aging agent that clears senescent cells and improves metabolic markers. Large‑scale fiber meta‑analyses show high intake (≈25 g/day) cuts all‑cause, cardiovascular, and cancer mortality by roughly 20‑25 %. Practical protocols recommend daily servings of viscous fibers, fermented foods, and walnuts to boost butyrate‑producing bacteria, while cautioning against abrupt fiber loading and unstandardized probiotic pills. Critics note healthy‑user bias in observational studies and limited RCT evidence for lifespan extension, underscoring the need for targeted, evidence‑based fiber strategies.

Predicting Alzheimers & Dementia (and Minimizing Risk)
Recent epidemiological studies show that high intake of omega‑3 fatty acids from oily fish dramatically lowers dementia risk. The Framingham Offspring cohort found a 49% reduction in Alzheimer’s disease for participants with the highest red‑blood‑cell DHA levels, while a UK...
Reviewing What Is Known of the Natural Rejuvenation Taking Place During Reproduction
Recent research highlights that mammalian oocytes possess a built‑in rejuvenation program that resets biological age, allowing offspring to begin life biologically young even when derived from aged parents. The article reviews how epigenetic reprogramming, mitochondrial quality control, and proteostasis cooperate...

Rethinking Insulin Resistance in Aging: A Reserve-Oriented Clinical Framework (Paper July 2026)
A new reserve‑oriented framework redefines insulin resistance in older adults, emphasizing muscle quality, mitochondrial health, and functional biomarkers over simple weight loss. The paper outlines actionable interventions—including SGLT2 inhibitors, senolytic fisetin, intranasal insulin, nicotinamide riboside, and weekly semaglutide—each supported by...
Rapamycin (Sirolimus) Clinical Evidence Guide: 2026 Medical Standards
The 2026 Clinical Evidence Guide positions rapamycin as the most validated geroprotector, recommending a weekly 3‑8 mg pulse to trigger autophagy while sparing mTORC2 and avoiding insulin resistance. Metformin remains a cornerstone for glucose control and modest longevity benefits, yet its...
MOTS-C Clinical Evidence Guide: 2026 Medical Standards
MOTS‑c, a mitochondrial‑derived peptide, is being positioned as a potent exercise mimetic that activates AMPK, reverses insulin resistance, and boosts skeletal‑muscle endurance. Preclinical models demonstrate complete prevention of diet‑induced obesity, dramatic endurance gains, and protection against osteopenia. Human data remain...
GHK-Cu (Copper Peptide) Clinical Evidence Guide: 2026 Medical Standards
GHK‑Cu, an endogenous copper‑binding tripeptide, is now classified under 2026 medical standards as a systemic epigenetic modulator, not just a cosmetic agent. Clinical consensus rates its collagen‑boosting effect as stronger than Vitamin C and tretinoin, while also showing moderate evidence for...

Matt Kaeberlein's New Longevity Science Podcast / Youtube Channel (May, 2026)
Matt Kaeberlein launched a new longevity‑focused podcast and YouTube channel in May 2026, using the platform to warn clinicians and consumers about the growing gray market for unapproved mitochondrial activators. The inaugural episode contrasts historic DNP tragedies with today’s synthetic pan‑ERR...

Best Biomarkers and New Biological Age, Bortz Blood Age Calculator (Free)
The Bortz Biological Age Clock, built on UK Biobank data from over 306,000 participants, leverages 25 blood biomarkers to estimate physiological age. Using an elastic‑net Cox regression and an actuarial conversion, the model achieves a concordance index of 0.778, surpassing...

Dasatinib and Quercetin as Senolytic May Cause Brain Damage
Dr. Natalia Mitten argues that total white‑blood‑cell counts mask age‑related immune shifts, making high‑resolution profiling of T‑cell p16^INK4a and TCF7 essential for assessing Immune Resilience (IR). Her SapereX "Hexagon" model links six immune domains to a composite Immune Longevity Score,...

Matt Kaeberlein's New Longevity Science Podcast / Youtube Channel (May, 2026)
Matt Kaeberlein and Brian Kennedy introduced LinAge, a second‑generation mortality‑risk clock built on standard clinical chemistry panels, positioning it as a reproducible alternative to first‑generation DNA‑methylation clocks. They highlighted the technical instability and lack of clinical actionability of epigenetic clocks,...
A Cross-Species Transcriptomic Aging Clock
Researchers combined more than 11,000 transcriptomes from mouse, rat, macaque and human tissues to create a cross‑species transcriptomic aging clock. The model accurately predicts chronological age, time‑to‑death and mortality‑linked disease risk, uncovering conserved gene signatures such as CDKN1A and LGALS3....

The Inflammation Paradox: Why Molecular Swapping in the IL-6 Pathway Dictates Human Lifespan
Statins lower circulating interleukin‑6 (IL‑6) through cholesterol‑independent, pleiotropic actions that inhibit prenylation of Rho‑family GTPases and suppress NF‑κB signaling. A network‑meta‑analysis ranking shows atorvastatin achieving the greatest IL‑6 reduction (35‑44%), while rosuvastatin’s effect ranges from negligible to 56% depending on...
Gut Microbiome Derived or Supplemented Glutamic Acid Improves the Quality of Aged Oocytes
A new open‑access study shows that transplanting gut microbiota from young donors or directly supplementing glutamic acid restores the quality of aged oocytes in mice. The researchers linked the effect to Bacteroides caecimuris‑derived glutamic acid, which enhances mitochondrial function and reduces...

Dr Brian Kennedy – Validating Aging Interventions and Why Rapamycin Is the Gold Standard
Singapore’s government is partnering with Prof. Brian Kennedy’s laboratory to launch the nation’s first human longevity studies, beginning with exercise and supplement protocols. A rapamycin trial is slated for early 2023, involving about 80 volunteers over six months and will...